MOUNJARO®

What Makes MOUNJARO® Unique

With MOUNJARO® (tirzepatide), medical excellence and refined innovation converge. This once-weekly injectable therapy embodies clinical precision while offering a sophisticated solution for practitioners who seek both reliability and elegance in treatment outcomes.

• Dual action on both GIP and GLP-1 receptors

• Designed for type 2 diabetes management and weight regulation

• Provides measurable improvements in glycaemic control and body composition

• Crafted for weekly administration, reducing treatment complexity

Why Practitioners Choose MOUNJARO®

Discerning clinicians value MOUNJARO® for its balance of science, safety, and elevated patient experience. Each dose reflects a commitment to both therapeutic effect and the refinement of modern care.

• Demonstrated HbA1c reductions with clinical consistency

• Supports meaningful weight reduction and improved insulin sensitivity

• Integrates seamlessly with existing antidiabetic regimens

• An exclusive solution trusted across diverse patient profiles

The MOUNJARO® Collection

The MOUNJARO® portfolio offers a range of thoughtfully calibrated strengths, allowing practitioners to tailor dosing with both precision and grace. Each option is presented in an elegantly engineered delivery system.

• Available in 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg doses

• Offered as KwikPen® pre-filled pens, single-dose vials, and multi-dose formats

• Each pen delivers 4 weekly injections, ensuring practicality with sophistication

• A transparent, clear to lightly yellow solution, signifying purity of formulation

Who Is MOUNJARO® Best For?

MOUNJARO® is designed for adults where medical refinement is a necessity—those requiring elegant control of type 2 diabetes or sustainable weight management. The therapy aligns with patients who demand both clinical efficacy and a premium care experience.

• Adults with insufficiently controlled type 2 diabetes

• Individuals with BMI ≥30 kg/m² (obesity)

• Adults with BMI ≥27 kg/m² to <30 kg/m² and weight-related conditions such as hypertension, dyslipidaemia, OSA, cardiovascular disease, prediabetes, or type 2 diabetes

• Not advised in cases of hypersensitivity to tirzepatide or severe gastrointestinal disease

What’s Inside: Active Components of MOUNJARO®

At the heart of MOUNJARO® lies its refined active substance, balanced with supportive excipients to ensure purity and consistency.

• Tirzepatide as the exclusive active ingredient

• Concentration tailored per pen strength (e.g., 5 mg/0.6 mL, 10 mg/0.6 mL)

• Contains benzyl alcohol in KwikPen® presentations (~5.4 mg per 0.6 mL dose)

• Classified as essentially sodium-free (<1 mmol sodium per dose)

• Solution appearance: Clear, colourless to slightly yellow

How to Use MOUNJARO® Effectively

Administration is designed with simplicity and refinement, ensuring a seamless experience for both practitioner and patient.

• Starting dose: 2.5 mg once weekly for 4 weeks

• Dose increases in 2.5 mg increments after ≥4 weeks on a stable dose

• Maintenance doses: 5 mg, 10 mg, or 15 mg weekly

• Administer subcutaneously in the abdomen, thigh, or upper arm

• Injection day can be changed, provided at least 3 days separate doses

MOUNJARO® Storage Guidelines

To preserve its clinical integrity, MOUNJARO® must be stored under carefully refined conditions.

• Unopened pens: Refrigerate at 2°C to 8°C

• Do not freeze; discard if frozen

• After first use, pens may be stored at ≤30°C for up to 30 days

• Always remove needles after use and discard safely

• Keep out of reach of children and away from direct heat

Potential Reactions and Safety Notes - MOUNJARO® Side Effects

MOUNJARO® is well-tolerated, with most reactions being mild to moderate and often diminishing over time. Clinicians are reassured by its well-documented safety profile.

• Gastrointestinal effects: nausea, diarrhoea, vomiting, constipation (most common)

• Hypoglycaemia risk: especially with sulphonylurea or insulin combinations

• Injection-site reactions: erythema or pruritus, typically mild

• Gallbladder-related events: observed in a minority of patients

• Rare: reports of acute pancreatitis and hypersensitivity

Order MOUNJARO® with Confidence

When you buy MOUNJARO® or order MOUNJARO® wholesale, you invest in a therapy that embodies both clinical precision and an elevated treatment philosophy. Each presentation is engineered for reliability, safety, and luxury in practice.

• Buy MOUNJARO® online with the assurance of authenticity

• Available in multiple strengths to suit refined patient needs

• Supported by a comprehensive clinical profile

• Trusted by practitioners committed to excellence

MOUNJARO® FAQs

MOUNJARO® elegantly bridges science and sophistication, making it a sought-after choice for modern practices.

• What is MOUNJARO® used for? Type 2 diabetes control and adult weight management.

• How often is it taken? Once weekly.

• What if a dose is missed? Take within 4 days, or skip if beyond.

• Can it be used during pregnancy? Not recommended; discontinue at least 1 month before planned pregnancy.

• How is it stored? Refrigerated, or at room temperature (≤30°C) for 30 days after first use.